PTK2 and hepatocellular carcinoma: Consistently, PST-mediated inhibition of plectin attenuates FAK, MAPK/Erk, and PI3K/Akt pathways in HCC cells with efficacy comparable to CRISPR/Cas-9-engineered functional (ΔIFBD) or full (KO) knockouts.